32360 Federal Register / Vol. 66, No. 115 / Thursday, June 14, 2001 / Notices

(FDA). The meeting will be open to the

public.

Name of Committee: Orally Inhaled

and Nasal Drug Products Subcommittee

of the Advisory Committee for

Pharmaceutical Science.

General Function of the Committee:

To provide advice and

recommendations to the agency on

FDA’s regulatory issues.

Date and Time: The meeting will be

held on July 17, 2001, from 8:30 a.m. to

5:30 p.m.

Location: Center for Drug Evaluation

and Research Advisory Committee

conference room 1066, 5630 Fishers

Lane, Rockville, MD.

Contact: Nancy Chamberlin, Center

for Drug Evaluation and Research (HFD–

21), Food and Drug Administration,

5600 Fishers Lane (for express delivery,

5630 Fishers Lane, rm. 1093) Rockville,

MD 20857, 301–827–7001, or e-mail:

CHAMBERLINN@cder.fda.gov, or FDA

Advisory Committee Information Line,

1–800–741–8138 (301–443–0572 in the

Washington, DC area), code 12539.

Please call the Information Line for upto-date information on this meeting.

Agenda: The subcommittee meeting

will discuss the issue of dose-response

of locally acting nasal sprays and nasal

aerosols, with particular application to

bioequivalence studies.

Procedure: Interested persons may

present data, information, or views,

orally or in writing, on issues pending

before the committee. Written

submissions may be made to the contact

person by July 10, 2001. Oral

presentations from the public will be

scheduled between approximately 11:30

a.m. to 12:30 p.m. Time allotted for each

presentation may be limited. Those

desiring to make formal oral

presentations should notify the contact

person before July 10, 2001, and submit

a brief statement of the general nature of

the evidence or arguments they wish to

present, the names and addresses of

proposed participants, and an

indication of the approximate time

requested to make their presentation.

Notice of this meeting is given under

the Federal Advisory Committee Act (5

U.S.C. app. 2).

Dated: June 6, 2001.

Linda A. Suydam,

Senior Associate Commissioner.

[FR Doc. 01–14929 Filed 6–13–01; 8:45 am]

BILLING CODE 4160–01–S

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Care Financing Administration

[HCFA–10043]

Agency Information Collection

Activities: Proposed Collection;

Comment Request

AGENCY: Health Care Financing

Administration, HHS.

In compliance with the requirement

of section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Health Care Financing Administration

(HCFA), Department of Health and

Human Services, is publishing the

following summary of proposed

collections for public comment.

Interested persons are invited to send

comments regarding this burden

estimate or any other aspect of this

collection of information, including any

of the following subjects: (1) The

necessity and utility of the proposed

information collection for the proper

performance of the agency’s functions;

(2) the accuracy of the estimated

burden; (3) ways to enhance the quality,

utility, and clarity of the information to

be collected; and (4) the use of

automated collection techniques or

other forms of information technology to

minimize the information collection

burden.

Type of Information Collection

Request: New Collection; Title of

Information Collection: Evaluation of

the BadgerCare Medicaid

Demonstration; Form No.: HCFA–10043

(OMB #0938–NEW); Use: The subject

surveys are components of the HCFA

evaluation of the Wisconsin BadgerCare

Section 1115 Medicaid demonstration

and Title XXI (SCHIP) program. The

goals of the evaluation are to assess the

effectiveness of BadgerCare in reducing

the number of Wisconsin residents who

lack health insurance, increasing

participation of eligible children in the

SCHIP program, and supporting families

making transitions from welfare to

work. Other specific features of

BadgerCare will be examined as well,

including the State’s outreach efforts

and policy of charging premiums to

selected families. Findings from the

study will help to inform HCFA policy

regarding Medicaid demonstrations and

SCHIP, and will help states in designing

similar health insurance programs.;

Frequency: Other: One time; Affected

Public: Individuals or Households;

Number of Respondents: 5,680; Total

Annual Responses: 5,680; Total Annual

Hours: 1,914.

To obtain copies of the supporting

statement and any related forms for the

proposed paperwork collections

referenced above, access HCFA’s Web

Site address at http://www.hcfa.gov/

regs/prdact95.htm, or E-mail your

request, including your address, phone

number, OMB number, and HCFA

document identifier, to

Paperwork@hcfa.gov, or call the Reports

Clearance Office on (410) 786–1326.

Written comments and

recommendations for the proposed

information collections must be mailed

within 60 days of this notice directly to

the HCFA Paperwork Clearance Officer

designated at the following address:

HCFA, Office of Information Services,

Security and Standards Group, Division

of HCFA Enterprise Standards,

Attention: Dawn Willinghan, HCFA–

10043, Room N2–14–26, 7500 Security

Boulevard, Baltimore, Maryland 21244–

1850.

Dated: June 5, 2001.

John P. Burke III,

HCFA Reports Clearance Officer, HCFA Office

of Information Services, Security and

Standards Group, Division of HCFA

Enterprise Standards.

[FR Doc. 01–14946 Filed 6–13–01; 8:45 am]

BILLING CODE 4120–03–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Care Financing Administration

[HCFA–2746]

Agency Information Collection

Activities: Proposed Collection;

Comment Request

AGENCY: Health Care Financing

Administration, HHS.

In compliance with the requirement

of section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Health Care Financing Administration

(HCFA), Department of Health and

Human Services, is publishing the

following summary of proposed

collections for public comment.

Interested persons are invited to send

comments regarding this burden

estimate or any other aspect of this

collection of information, including any

of the following subjects: (1) The

necessity and utility of the proposed

information collection for the proper

performance of the agency’s functions;

(2) the accuracy of the estimated

burden; (3) ways to enhance the quality,

utility, and clarity of the information to

be collected; and (4) the use of

automated collection techniques or

other forms of information technology to

minimize the information collection

burden.